The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 9.70 — safe zoneOK
- Earnings-manipulation signal · Beneish M -1.37 — flag raised, worth a closer lookWatch
- Earnings quality 58/100 — worth a closer lookWatch
Where the revenue comes from
Fiscal 2025, as BGM Group Ltd. reports it. History and quarterly detail are in the app.
- Diversified Pharmaceutical And Allied Products$23.6M
- Insurance Business$11.0M
- Ai Solutions$3.4M
Latest filings
- 6-K · Company announcement (foreign filer)2026-08-28
- 6-K · Company announcement (foreign filer)2026-08-11
- 6-K · Company announcement (foreign filer)2026-07-30
- 6-K · Company announcement (foreign filer)2026-07-28
- 20-F · Annual report (foreign filer)2026-07-21
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about BGM Group Ltd., every answer cited to the official filings🔒
- The Intelligence Brief — added when BGM Group Ltd.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.